FIELD: medicine.
SUBSTANCE: it involves sampling of immune specific serums containing antibodies to basic virus antigens and having various concentrations of these antibodies, and also sampling of healthy donor serums with a null titre. Serum sampling for a performance panel is ensured by the PCR-analysis data for viral RNA and separate protein titration in immune-enzyme assay. The immune specific serums are those which have the optical density shown by immune-enzyme assay less than a critical optical density.
EFFECT: method enables a correct assessment of serologic assay data and higher quality control of sensitivity and specificity of test systems and immunoblots.
6 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PANEL OF SERUMS CONTAININS ANTIBODIES TO HCV ANTIGENS OF VARIOUS SUBTYPES | 2010 |
|
RU2456617C2 |
| METHOD OF PRODUCING OF REFERENCE PANEL FOR QUALITY CONTROL OF TEST SYSTEMS AND IMMUNOBLOTS USED FOR SERUM DIAGNOSIS OF HIV-1 MARKERS | 2015 |
|
RU2603483C2 |
| METHOD OF PREPARING STANDARD PANEL OF SERA TO CONTROL QUALITY OF TEST SYSTEMS AND IMMUNOBLOTS USED FOR SEROLOGIC DIAGNOSTICS OF ANTIBODIES SPECIFIC FOR VIRAL INFECTIONS | 1995 |
|
RU2122741C1 |
| METHOD FOR MAKING OPERATIONAL STANDARD OF SERUMS CONTAINING ANTIBODIES TO HEPATITIS C VIRUS | 2008 |
|
RU2380711C2 |
| METHOD FOR MAKING SERUM PANEL FOR EVALUATION OF ANTIBODIES TO HEPATITIS B VIRUS | 2007 |
|
RU2367960C2 |
| METHOD FOR PRODUCING REFERENCE PANEL FOR SERUM SAMPLES TO ASSESS SPECIFICITY OF SERODIAGNOSTIC RESULTS OF SOCIALLY SIGNIFICANT DISEASES | 2013 |
|
RU2521232C1 |
| MASTER-PANELS OF SERA COMPRISING AND NOT COMPRISING HBsAg AND METHOD FOR ITS PREPARING | 2005 |
|
RU2314540C2 |
| METHOD OF MAKING PANELS OF SERA OF DIFFERENT SUB-TYPES AND GENOTYPES OF HEPATITIS B VIRUS FOR CONTROLLING QUALITY OF HEPATITIS B DIAGNOSIS | 2006 |
|
RU2346282C2 |
| METHOD FOR PREPARING WORKING STANDARD SERUM COMPRISING HBsAg AY AND AD SUBTYPES | 2004 |
|
RU2271011C1 |
| METHOD FOR PRODUCING REFERENCE PALETTE FOR CONTROLLING TEST-SYSTEMS AND VACCINES AGAINST HEPATITIS B | 1999 |
|
RU2181893C2 |
